For example, Rivera et al. at Charité–Universitätsmedizin Berlin tested 49 CRC PDX models with standard drugs and found a strong association between B-RAF, EGFR, and KRAS copy numbers and sensitivity to cetuximab and erlotinib.34 This evidence concerns the gene EGFR and colorectal carcinoma.